Infections

Guidance and services

• Patient testing framework for autumn/winter 2023 (WHC/2023/037)
• Patient testing framework, updated guidance (WHC/2023/07)
• COVID-19 patient testing framework (WHC/2022/011)
• Pertussis vaccination for healthcare workers (WHC/2019/024)
• Healthcare workers infected with bloodborne viruses (WHC/2019/023)
• Implementing recommendations of the review of sexual health services (WHC/2019/011)
• Changes to the shingles immunisation programme (WHC/2019/008)
• Eligibility for non routine immunisations (WHC/2018/048)
• Supply and ordering of BCG vaccine (WHC/2018/034)
• Antimicrobial resistance (WHC/2018/020)
• Diagnosing and treating Lyme disease (WHC/2018/021)
• Attaining the WHO targets for eliminating hepatitis B and C (WHC/2017/048)
• Healthcare workers infected with bloodborne viruses (WHC/2017/045)
• Hexavalent vaccine for baby immunisation schedule (WHC/2017/039)
• Changes to the shingles immunisation programme (WHC/2017/017)
• Reducing healthcare associated infections (WHC/2017/011)
• Cessation of antenatal rubella screening (WHC/2016/038)
• Removal of the meningococcal serogroup C (MenC) vaccine for babies (WHC/2016/027)
• Change to the pertussis vaccination programme for pregnant women (WHC/2016/020)
• Carbapenemase producing Enterobacteriaceae: infection prevention and control (WHC/2016/007)
• Decontamination of medical devices (WHC/2015/050)
• Aseptic non-touch technique (ANTT): introduction of a standardised approach (WHC/2015/047)
• Introduction of MenB immunisation for infants (WHC/2015/040)
• Meningococcal ACWY conjugate vaccination (WHC/2015/037)
• Changes to the shingles vaccination programme (WHC/2015/019)
• Health protection legislation: 2010 guidance
• Getting support for recovery from COVID-19 (long COVID)
• Directed enhanced service: influenza immunisation for those in the 65 and over and other at-risk groups
• Continuation of immunisation programmes during the COVID-19 pandemic: letter from CMO (WHC/2020/006)
• The national influenza immunisation programme 2021 to 2022 (WHC/2021/019)
• Healthcare associated infection, device usage and antimicrobial usage survey (WHC/2017/005)
• Changes to the vaccine for the HPV immunisation programme (WHC/2022/023)
• Healthcare associated infections and antimicrobial resistance improvement goals (WHC/2022/014)
• The national influenza immunisation programme 2020 to 2021 (WHC/2020/009)
• Reimbursable vaccines and eligible cohorts for the 2023 to 2024 NHS seasonal influenza (flu) vaccination programme (WHC/2022/031)
• Ordering influenza vaccines for 2020 to 2021 (WHC/2019/037)
• Reimbursable vaccines and eligible cohorts for the 2022 to 2023 NHS seasonal influenza (flu) vaccination programme (WHC/2022/010)
• The national influenza immunisation programme 2020 to 2021 (WHC/2020/013)
• Influenza (flu) vaccination programme deployment ‘mop up’ 2022 to 2023 (WHC/2022/035)
• Patient data record: flu vaccination
• Sepsis Trust's 'Spotting the unwell child'
• Health workers with bloodborne viruses (BBV), and TB clearance (WHC/2023/035)
• Eligible groups in the 2025 to 2026 flu immunisation programme
• Mpox and gonorrhoea vaccination programme details: 2025

Policy and background Includes strategy, reports, projects and assessments.

• Healthcare associated infections
  Policy and strategy
• Healthcare associated infections: code of practice
  Policy and strategy
• UK COVID-19 Inquiry: Welsh Government responses to module reports
  Collection
• Antimicrobial resistance delivery plan 2016
  Policy and strategy
• Health protection Part 2A orders 2010 to 2022
  Report
• Healthcare associated infections: community strategy
  Policy and strategy
• Contaminated blood: financial support survey responses
  Report
• The Health Protection (Coronavirus Restriction) (Functions of Local Authorities) (Wales) Regulations 2020
  Legislation
• HIV action plan for Wales 2023 to 2026
  Policy and strategy
• The Health Protection (Notification) (Wales) (Amendment) Regulations 2020
  Legislation
• Wastewater monitoring reports: coronavirus
  Collection
  Technical Advisory Cell
• The Health Protection (Coronavirus) (Wales) Regulations 2020 (revoked)
  Legislation
• Technical Advisory Cell: review cycles
  Collection
  Technical Advisory Cell
• Technical Advisory Cell: summary of coronavirus advice
  Collection
  Technical Advisory Cell
• Technical Advisory Group: modelling updates and subject specific reports
  Collection
  Technical Advisory Cell
• Science Evidence Advice: communicable disease surveillance reports
  Collection
  Technical Advisory Cell
• Spotting sepsis in children, awareness leaflet (WHC/2024/045)
  Policy and strategy
• Change to the influenza vaccination programme 2024 to 2025 (WHC/2024/046)
  Policy and strategy
• Introduction of routine vaccinations for mpox and gonorrhoea (WHC/2025/021)
  Policy and strategy
• The national influenza immunisation programme 2025 to 2026 (WHC/2025/020)
  Policy and strategy
• Expansion of shingles immunisation for severely immunosuppressed people aged 18 to 49 (WHC/2025/028)
  Policy and strategy
• Introduction of a new RSV passive immunisation from autumn 2025 (WHC/2025/029)
  Policy and strategy
• Infected blood inquiry: implementing recommendation 7e, SHOT reports (WHC/2025/037)
  Policy and strategy
• Antimicrobial resistance and healthcare associated infection improvement goals: 2025 to 2027 (WHC/2025/039)
  Policy and strategy
• Routine varicella (chickenpox) vaccination for young children from 1 January 2026 (WHC/2025/046)
  Policy and strategy